(19)
(11) EP 1 846 377 A2

(12)

(88) Date of publication A3:
07.12.2006

(43) Date of publication:
24.10.2007 Bulletin 2007/43

(21) Application number: 06701524.8

(22) Date of filing: 19.01.2006
(51) International Patent Classification (IPC): 
C07D 231/12(2006.01)
A61K 31/415(2006.01)
(86) International application number:
PCT/IB2006/000190
(87) International publication number:
WO 2006/079923 (03.08.2006 Gazette 2006/31)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 31.01.2005 US 648509 P

(71) Applicant: Pharmacia & Upjohn Company LLC
Kalamazoo, MI 49001 (US)

(72) Inventors:
  • HAWLEY, Michael, Pfizer Inc.
    Kalamazoo, MI 49001 (US)
  • LU, Guang Wei, Pfizer Global Res. and Development
    Ann Arbor, MI 48105 (US)
  • GEIGER, Brenda, Mae,c/o Pfizer Global R and D
    Sandwich, Kent CT13NJ (GB)
  • SMITH, Mark Alan, Pfizer Inc.
    Kalamazoo, MI 49001 (US)
  • GAO, Ping, Pfizer Global Research and Development
    Ann Arbor, MI 48105 (US)
  • HAGEMAN, Michael, John,c/o Pfizer Global R and D
    Sandwich, Kent CT13NJ (GB)
  • EWING, Gary, Douglas,c/o Pfizer Global R and D
    Sandwich, Kent CT13NJ (GB)

(74) Representative: Dekker, Henrike Cornelie Christine 
Pfizer European Pharma Patent Department 23-25, avenue du Docteur Lannelongue
75668 Paris Cedex 14
75668 Paris Cedex 14 (FR)

   


(54) FORM IV CRYSTALLINE CELECOXIB